Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Anticancer oligonucleotides from Taiho

July 26, 1996

Human Genome Sciences' VIGF antagonists in pipeline

July 26, 1996

New formulation of CGP-41251

July 26, 1996

Tyrosine kinase inhibitors in Pharmacia & Upjohn's pipeline

July 26, 1996

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Suppressin from pituitary extract described by the University of Alabama

July 19, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...